Athenex, Inc.
ATNXNASDAQHealthcare
$0.20
+$0.00(+0.00%)
Market Cap$2333680
P/E Ratio—
52W High$23.8
52W Low$0.081
Athenex, Inc. (ATNX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ATNX · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2023Report Date: Mar 20, 2023EPS Actual
-$3.38
Est. -$1.00 · -238.0%
Revenue
$0.03B
Est. $0.03B · -15.6%
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Mar 20, 2023
After Market Close
▼ Miss EPS▼ Miss Revenue
ATNX reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2024 | Mar 18, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 1, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Jul 26, 2023 | -$1.71 | — | — | — | $0.02B | — |
| ◌ Q2 FY2023 | May 23, 2023 | $1.71 | — | — | — | $0.02B | — |
| ▼ Q1 FY2023 | Mar 20, 2023 | -$1.00 | -$3.38 | -238.0% | $0.03B | $0.03B | -15.6% |
| ▲ Q4 FY2022 | Nov 3, 2022 | -$3.20 | -$2.80 | +12.5% | $0.03B | — | — |
| ▼ Q3 FY2022 | Jul 28, 2022 | -$2.60 | -$4.60 | -76.9% | $0.03B | $0.02B | +34.7% |
| ▼ Q2 FY2022 | May 10, 2022 | -$3.20 | -$4.80 | -50.0% | $0.03B | $0.03B | -13.6% |
Q1 FY2024
Mar 18, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 1, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Jul 26, 2023
EPS Actual
—
EPS Est.
-$1.71
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 23, 2023
EPS Actual
—
EPS Est.
$1.71
EPS Surpr.
—
Revenue
—
Q1 FY2023
Mar 20, 2023Miss
EPS Actual
-$3.38
EPS Est.
-$1.00
EPS Surpr.
-238.0%
Revenue
$0.03B
Q4 FY2022
Nov 3, 2022Beat
EPS Actual
-$2.80
EPS Est.
-$3.20
EPS Surpr.
+12.5%
Revenue
$0.03B
Q3 FY2022
Jul 28, 2022Miss
EPS Actual
-$4.60
EPS Est.
-$2.60
EPS Surpr.
-76.9%
Revenue
$0.03B
Q2 FY2022
May 10, 2022Miss
EPS Actual
-$4.80
EPS Est.
-$3.20
EPS Surpr.
-50.0%
Revenue
$0.03B
No analyst estimates available for ATNX.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2023 | Mar 20, 2023 | -238.0% | $1.76 | $1.26 | -28.41% |
| ▲ Q4 FY2022 | Nov 3, 2022 | +12.5% | $3.97 | $4.00 | +0.65% |
| ▼ Q3 FY2022 | Jul 28, 2022 | -76.9% | $10.74 | $10.49 | -2.33% |
| ▼ Q2 FY2022 | May 10, 2022 | -50.0% | $9.33 | $10.20 | +9.35% |
| ▼ Q1 FY2022 | Mar 16, 2022 | -625.0% | $17.10 | $19.20 | +12.28% |
| ▲ Q4 FY2021 | Nov 4, 2021 | +19.5% | $53.80 | $50.20 | -6.69% |
| ▲ Q3 FY2021 | Aug 5, 2021 | +19.5% | $74.20 | $76.80 | +3.50% |
| ▲ Q2 FY2021 | May 6, 2021 | +27.0% | $91.00 | $85.60 | -5.93% |
Q1 FY2023-28.41%
Report Date
Mar 20, 2023
EPS Beat/Miss
-238.0%
Price Before
$1.76
Price After
$1.26
Q4 FY2022+0.65%
Report Date
Nov 3, 2022
EPS Beat/Miss
+12.5%
Price Before
$3.97
Price After
$4.00
Q3 FY2022-2.33%
Report Date
Jul 28, 2022
EPS Beat/Miss
-76.9%
Price Before
$10.74
Price After
$10.49
Q2 FY2022+9.35%
Report Date
May 10, 2022
EPS Beat/Miss
-50.0%
Price Before
$9.33
Price After
$10.20
Q1 FY2022+12.28%
Report Date
Mar 16, 2022
EPS Beat/Miss
-625.0%
Price Before
$17.10
Price After
$19.20
Q4 FY2021-6.69%
Report Date
Nov 4, 2021
EPS Beat/Miss
+19.5%
Price Before
$53.80
Price After
$50.20
Q3 FY2021+3.50%
Report Date
Aug 5, 2021
EPS Beat/Miss
+19.5%
Price Before
$74.20
Price After
$76.80
Q2 FY2021-5.93%
Report Date
May 6, 2021
EPS Beat/Miss
+27.0%
Price Before
$91.00
Price After
$85.60
Avg Beat Reaction-2.12%
Avg Miss Reaction-2.28%
Beat Rate4 / 8 quarters
Largest Move-28.41% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ATNX ends December
Athenex, Inc. (ATNX) most recently reported earnings on March 20, 2023 for Q1 FY2023, posting EPS of $-3.38 — missing the analyst consensus of $-1.00 by -238.0%. The next ATNX earnings date is expected around September 1, 2026.
Each quarter, investors track ATNX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ATNX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ATNX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ATNX earnings · 5 questionsAthenex, Inc.'s next earnings report is expected around September 1, 2026. ATNX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ATNX historically reports after market close (AMC).
ATNX earnings datewhen is ATNX earningsATNX next earnings datewhen does ATNX report earningsATNX earnings calendar
▸ Source: FMP · Athenex, Inc. SEC filings · US GAAP · Athenex, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026